Status:
UNKNOWN
Anemia of Inflammation and Deficiency Anemia
Lead Sponsor:
Iuliu Hatieganu University of Medicine and Pharmacy
Conditions:
Anemia, Iron Deficiency
Anemia of Chronic Disease
Eligibility:
All Genders
18+ years
Brief Summary
Critical patients which requiring admission to intensive care (IT) are a special group of patients. In these patients the prevalence of anemia reported in studies is 75%. This prevalence is similar to...
Eligibility Criteria
Inclusion
- Patients admitted to ICU
- ICU stay \>48hours
Exclusion
- Refusal to participate in the study
- Allergy to iron products
- Anemia requiring massive transfusion in the last 7 days
- Treatment of iron products in the last 7 days
- Chronic renal failure with GFR \<30mL / min or on dialysis
- Metabolism of iron
- Pregnant or lactation patients
- Rheumatic diseases
- Inflammatory bowel diseases
- Hematological pathologies
- Impossibility of performing laboratory tests within 72 hours of admission
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04071067
Start Date
January 1 2020
End Date
July 1 2021
Last Update
August 28 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Emergency Clinical County Hospital Cluj Napoca
Cluj-Napoca, Cluj, Romania
2
Municipal Clinical Hospital Cluj
Cluj-Napoca, Cluj, Romania